Member Info for Troutisout1

"Great cash at bank when you consider all the drills have been funded and paid for. Cobre will just keep replenishing the coffers while the drills keep multiplying the value of Cornwall.""

Not quite, CRL do the drilling work and then invoice Cornwall Council at each stage, so there will be a lot more of the grant money to come.

One man's loss is another's gain, It was only the Daniel Holloway selling that got me really interested and allowed me to build a good sized holding...

The write up is likely to be his own, last time he quoted something that wasn't there...

Looks to me like Institutions are trying to buy in and the MMs are holding back the price to fill orders. Plenty of twinned trades now at slightly different prices but not set out like rollovers with the sell first, so don't think they are rollovers.

Not bothered by the very short term moves, as the short term will produce more newsflow and I would still like to buy some more soon.

You two make it sound like what they do is unique, there are many other larger companies out there fighting for the same market and they are bigger and more robust, with larger order books and larger client bases. Yes PYC is likely to grow but how much? And by what means? They don't seem to be able to get enough margin on their current business to make decent profits and is this a sign they have to discount to get business? Many other CRO's offer further services that help clients with their drug discovery and ultimately development. PYC can't do that.

Just look at the contract sizes this year the biggest one was probably Burt's 14m share price purchase in January, if there were 2 or 3 contracts a month going through then maybe they have something, but at the moment the proof is in the pudding and that has come up short for investors up to now...

The traded prices slowly edging up, looks to be a little more interest, we know that the SP isn't going to sit here and wait for the launch of OptiMAL, so people are all watching to see the first signs of life to jump onboard.

PYC are positioned in high growth markets, but they are not alone and most other companies have a scale much larger. Would you want to bring a large contract to PYC? Is this why they only seem to get smaller contracts? It's alright being a niche supplier, but it isn't going to scale quick enough in such a fast moving environment. There are other CROs doing the same thing and they already have the scale to take on many diverse projects at the same time and to also continue to develop their capabilities both in offering and size.

Burt, Have you seen SML? Since they got rid of the Australian Cowboys they have got their act together (a little luck with the current metals/minerals trade war going on with China and the West) and some stonking Tungsten grades, alongside Sn, Cu and Ag.

You kept using out of date inflated cash figures earlier this year until there was a placing, you seem to be doing the same again.

Fab at £1 would give it a valuation of £113.66m, I've told you a million times before Laura stop exaggerating...

How a thread ages after a fortnight...

What I noticed was this, "To highlight the valuation disparity, we note that Absci (Nasdaq: ABSI), a larger

US/Canadian-based firm that has an AI-led approach to antibody drug design, has a market

capitalisation of $728m, and an enterprise value of $618m (it has cash of $110m). "

Highlighting the cash pile of a competitor? Hmmm.....

That will be down to Laura trolling on another BB thread this morning, it was obviously quiet here so Laura decides to stir the pot and now the rest of you have to put up with it.

10Gordon10.

The individual investor is a Director of RAB, he has held around 80m shares for a long time, this was upped for the placing earlier this year, the sell notice yesterday shows his holding to be more than before the placing but he has obviously taken some off the table. If he was still working a sell he does not have to declare any TR1s until the order has been filled, the fact he has filed a TR1, suggests that is it for now. Of course we don't know for sure, what other investors are going to do, so we go on our own research and that is why I was buying more this morning on the drop.

Only Gordon Brown declares to the market he is going to continue selling down his asset beforehand...

Those last 5 x 100k sells are the delayed sells that started the tree shake, many of them below the now bid price and would have to pay even more to buy back in.

We should start to see the delayed buys come through now as the SP started to rise (although they weren't quoting more than 10k at the bottom of that trough, so not sure many would have got decent volume early on.

It's clearly not valued on it's revenue or even recent contracts, but on it's platforms which are gaining patents and been verified by the NCI in the US for the last two years. In fact they have stated they want to use it beyond the 2 year validation period which ends next month as it has been so successful in finding antibodies to bind to their cancer targets. This platform is being launched in December.

A simple read through will show the huge difference between the two CROs and their near time future, hence the difference in valuation, you obviously can't see that but no matter how much you try to make this something special, modelling for drug discovery is being done by everyone nowadays and AI/ML is being used to enhance the datasets and models they are using, quite what makes PYC stand out is beyond me, they seem to be at least 12-18 months before they even get to a product that can go out to be validated by clinicians.

The holding is that of an individual director of RAB held in a nominee company under the RAB umbrella. The shares sold were some of the recent placing shares he added and the new holding is more than the long term holding at the last full year results.

Looks to me like someone took some of their recent placing shares off the table for a decent profit, can't argue with that...

This footnote to resolution 10 for today's AGM, they don't have to put this bit in but have done so to re-assure,

"The directors have no current intention to exercise either of the authorities sought under resolution 10."

Druml, there is not likely to be any big seller, just a combination of lots of decent sized holdings skimming off a bit of profit.

I hold over 3m of these and know someone who has bought 1/2m in the last two days, including a 150k buy today that still is to be reported.

The MMs are offering and bidding in size and are making a good turn with this volume.

I think we will be getting a lot of material updates over the next 2 months and really believe the share price will be well above recent highs, so you either cave in to the BBs or you DYOR and follow your conviction.

Buyers getting stuck in at sub 14p...